Menu Mobile
Aguarde Carregando

VII International Symposium on Translational Oncology

Imagem do Evento: VII International Symposium on Translational Oncology
✪ Local: Medical School - Facisb | Barretos, SP - Brazil
Por:
Escolha a categoria
Código do evento: 74

VII International Symposium on Translational Oncology
Categoria do evento

O Hospital de Câncer de Barretos (HCB) conta com um Instituto de Ensino e Pesquisa (IEP), que congrega o Centro de Pesquisa em Oncologia Molecular (CPOM), Unidade de Pesquisa Clínica (UPC) e a Pós-Graduação em Oncologia, que constituem os alicerces para o desenvolvimento da oncologia do futuro, a medicina de precisão, nesta instituição. O CPOM é um centro avançado de pesquisa em oncologia molecular baseado nos mais modernos centros de pesquisa do mundo, viabilizando o acesso a recursos tecnológicos e laboratórios de citogenética, genética molecular, biologia molecular e celular, com estrutura que permite o desenvolvimento de pesquisas em diversas áreas da oncologia molecular. Assim, com o intuito de continuar a sua missão que é a de formar, divulgar e disseminar entre pesquisadores, oncologistas, residentes, alunos de pós-graduação, e demais profissionais de Saúde sobre os principais temas oncológicos da atualidade, o Instituto de Ensino e Pesquisa do Hospital do Câncer de Barretos está organizando o VII Simpósio Internacional de Oncologia Translacional do Hospital de Câncer de Barretos. Este evento, organizado por pesquisadores e médicos oncologistas do próprio instituto visa promover a discussão e interação entre o público alvo e pesquisadores de reconhecimento nacional e internacional, que desenvolvem seus trabalhos em centros de excelência nas diversas áreas da oncologia, o que contribuirá para a consolidação e melhora da medicina translacional e pesquisa clínica em oncologia no âmbito nacional e internacional.

Program

09/13/2019 (Friday)

07:30 am – 08:00 am – Registration
08:00 am – 08:10 am – Opening and Welcome 
Rui Manuel Reis, PhD (Barretos Cancer Hospital, Barretos, Brazil) - Scientific Director

 08:10 am – 10:10 am - Session 1
Hereditary Cancer and genetic risk factors
Discussion Leaders: Dirce Maria Carraro,PhD / Rui Manuel Reis, PhD

08:10 am 08:40 am –  Genetic analyses of a demographically defined population reveals new ovarian cancer predisposing gene candidates
Speaker: Patricia Tonin, PhD (McGill University Health Centre, Montrela, Canada) 

08:40 am 09:10 amDeciphering genetic susceptibility to lung cancer
Speaker: James McKay, PhD ( IARC, Lyon, France) 

09:10 am 09:40 amThe germline mutation landscape of Hereditary Breast Cancer in Brazil
Speaker: Edenir Inez Palmero, PhD (Barretos Cancer Hospital, Barretos, Brazil) 

09:40 am – 10:10 am – Discussion

10:10 am – 10:40 am – Coffee-break and visit to the posters.

10:40 am – 12:40 am – Session 2
Early detection and cancer screening

Discussion Leaders: Denise Peixoto Guimarães, MD, PhD / José Humberto T. G. Fregnani, MD,PhD 

10:40 am – 11:10 am –  The wide effect of microbiota on cancer
Speaker: Christian Jobin, MD, PhD (University of Florida, Gainesville, Florida) 

11:10 am – 11:40 am – What tools do we have to eliminate cervical cancer?
Speaker: Luisa Lina Villa, PhD ( Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil) 

11:40 am – 12:10 pm – Integration of molecular biology, molecular pathology and epidemiology: a new paradigm into the screening and surveillance of head and neck tumors
Speaker:
Ana Carolina de Carvalho Peters, PhD (Barretos Cancer Hospital, Barretos, Brazil) 

12:10 pm – 12:40 pm -  Discussion

12:40 pm – 1:00 pm –  Technical lecture

1:00 pm – 1:30 pm – Lunch

1:40 pm – 2:25 pm - Oral presentation of Best Abstracts
Discussion Leader:

1:30 pm – 1:40 pm –

1:40 pm – 1:50 pm –

1:50 pm –  2:00 pm -

2:00 pm – 2:15 pm – Discussion

2:15 pm – 4:15 pm – Session 3
Environmental factors and Exposome in cancer development

Discussion Leaders: Henrique Silveira, PhD / Fabiana de Lima Vazquez, PhD

2:15 pm – 2:45 pm – talk: t.b.a.
Speaker: Luis Felipe Ribeiro Pinto, PhD (National Cancer Institute – INCA, Rio de Janeiro, Brazil) 

2:45 pm – 3:15 pmExploring interactions between the exposome and cancer through metabolomics – Application to cohort studies
Speaker: Augustin Scalbert, PhD (International Agency for Research on Cancer -IARC, Lyon, France) 

3:15 pm – 3:45 pm – talk: t.b.a.
Speaker: Paulo Hilário Nascimento Saldiva, MD, PhD (Universidade de São Paulo, Instituto de Estudos Avançados USP, São Paulo, Brazil) 

3:45 pm – 4:15 pm - Discussion

4:15 pm – 6:15 pm – Session 4
Molecular biomarkers in translational oncology

Discussion Leaders: Patricia Reis, PhD  / Márcia Maria C. Silveira, PhD

4:15 pm – 4:45 pm –  Clonal hematopoiesis and malignant clonal evolution
Speaker:
Rodrigo Calado, PhD ( (FMRP/USP, Ribeirão Preto, Brazil) 

4:45 pm – 5:15 pm – Alterations of DNA methylation as biomarkers in tumors from the upper aerodigestive tract
Speaker:
Sheila Coelho Soares Lima, PhD (National Cancer Institute – INCA, Rio de Janeiro, Brazil) 

5:15 pm – 5:45 pmThe Molecular Landscape of Brazilian Lung Cancer: Searching for Clinically Relevant Biomarkers
Speaker:
Letícia Ferro Leal, PhD (Barretos Cancer Hospital, Barretos, Brazil) 

5:45 pm – 6:15pm – Discussion

 

09/14/2019 (Saturday)

 

07:30 am – 09:30 am – Session 5
Personalized Medicine

Discussion Leaders: Vinícius de Lima Vazquez, MD, PhD / Jeremy Andrew Squire, PhD 

07:30 am – 08:00 am – talk: t.b.a.
Speaker: talk: t.b.a.

08:00 am – 08:30 amThe Brazilian Initiative on Precision Medicine (BIPMed): contributions of the past four years
Speaker:
Iscia Lopes Centes, PhD ( UNICAMP, Campinas, Brazil) 

08:30 am – 09:00 am –  talk: t.b.a.
Speaker: St. Jude Children's Research Hospital

09:00 am – 09:30 am – Discussion

09:30 am – 10:00 am – Coffee-break and visit of the posters.

10:00 am – 12:00 pm – Session 6
Innovative approaches for cancer discovery and treatment

Discussion Leaders: Osvaldo Novais de Oliveira Jr, PhD /Matias Eliseo Melendez, PhD

10:00 am – 10:30 am – talk: t.b.a.
talk: t.b.a.

10:30 am – 11:00 am – The use of multi-omic data integration to reveal potential targets in HPV-related cancers
Speaker:
Marcelo Alves Soares, PhD (National Cancer Institute – INCA, Rio de Janeiro, Brazil)

11:00 am – 11:30 am – talk: t.b.a.
Speaker: Bertrand Jean Claude, PhD (University McGill, Montreal, Canada) 

11:30 am – 12:00 am – Discussion

12:00 pm – 12:20 pm –  Technical lecture

12:20 pm – 12:50 pm – Lunch

12:50 am – 2:10 pm – Session 7
Microambiente Imunoterapia

Discussion Leaders: Céline Marques Pinheiro, PhD / Flávio Carcano, MD, PhD

12:50 am – 12:40 pm –  Lactate and acidification represent metabolic checkpoints in the tumor environment
Speaker:
Marina Kreutz, PhD ( University Hospital Regensburg, Regensburg, Alemanha)

12:40 pm – 1:10 pm – talk: t.b.a.
Speaker: Kenneth Gollob, PhD (AC Camargo Cancer Center, São Paulo, Brazil)

1:10 pm – 1:40 pm – talk: t.b.a.
Speaker:

1:40 pm – 2:10 pm – Discussion

2:10 pm – 4:40 pm – Session 8
Modelos experimentais em Oncologia Translacional 

iscussion Leaders: Viviane Aline Saito, PhD / Silvia Teixeira, PhD

2:10 pm – 2:40 pm – Zika virus: from enemy  to ally
Speaker:
Dra. Mayana Zatz, PhD (University of São Paulo – São Paulo, Brazil) 

2:40 pm – 3:10 pm – Exploiting viruses for the treatment of brain tumors 
Speaker: Sean Edward Lawler, PhD (Brigham and Women's Hospital – Harvard Medical School - Boston, USA) 

3:10 pm – 3:40 pm – Immune cell therapies for cancer: future promises and challenges
Speaker:
Mohan Sobhana Nandhu, PhD (Takeda Pharmaceutical International Co, Cambridge, USA) 

3:40 pm – 4:10 pm – Discussion

4:10 pm – 4:40 pm – Discussion

4:40 pm – 5:00 pm – Awards of the best oral presentation and poster
iscussion Leader:

4:40 pm – 5:00 pm – Closing remarks.

5:00 pm – 5:30 pm - Farewell Coffee.

Committee

Executive and Scientific Committee

Ana Carolina Carvalho
Adriane Evangelista Feijó
Céline Marques Pinheiro
Denise Guimarães
Edenir Inez Palmero
Fabiana Vazquez
Henrique Cesar Santejo Silveira
Letícia Ferro Leal
Luis Fernando Lopes
Márcia Maria Chiquitelli Marques Silveira
Mariana Tomazini Pinto
Matias Melendez
Pedro de Marchi
Ricardo dos Reis
Rui Manuel Vieira Reis
Silvia Teixeira
Vinícius de Lima Vazquez
Vinicius Duval da Silva
Viviane Aline Saito

 

Organizing Committee

Bianca Cristina Pereira
Camila Argolo Muniz
Caio Fernando de Oliveira
Dorion Denardi
Joyce Silva Pinto

Registration Fees

Health professionals and PhD – R$ 350,00

Graduate students – R$ 250,00

Undergraduate students – R$ 150,00

Employees from Barretos Cancer Hospital - R$ 150,00

Cancellation deadline of  Inscription - seven days

Confirmed International Speakers

Augustin Scalbert, PhD
IARC – Lyon, France.

https://www.iarc.fr/staff_member/dr-augustin-scalbert/


Bertrand Jean Claude, PhD
MC Gill University, Montreal – Canadá.

https://www.mcgill.ca/expmed/dr-bertrand-jean-claude


Christian Jobin, MD, PhD
University of Florida, Gainesville – Florida, USA.

https://gastroliver.medicine.ufl.edu/about-us/meet-the-team/christian-jobin-ph-d/


James Mckay, PhD
IARC – Lyon, France.

https://www.iarc.fr/staff_member/dr-james-mckay/


Mohan Sobhana Nandhu, MD, PhD
State University of New York Upstate Medical University – New York, USA

https://www.researchgate.net/profile/Mohan_Sobhana_Nandhu


Patricia Tonin, PhD
MC Gill University – Montreal, Canadá.

http://rimuhc.ca/-/patricia-tonin


Sean Edward Lawler, PhD
Brigham and Women's Hospital – Boston, USA

https://connects.catalyst.harvard.edu/Profiles/display/Person/78460

 

 

Submit Abstract

DEADLINE TO SUBMIT ABSTRACT: 04/20/2019 - 06/30/2019

THE INFORMATIONS TO  PRESENTATION: CLICK HERE

,

Sponsors | Support
Todos direitos reservados © 1999 - 2019 Hospital de Câncer de Barretos.